Hyaline Fibromatosis Syndrome: Clinical Trials

3 trials for Hyaline Fibromatosis Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Hyaline Fibromatosis Syndrome: new trials by email Literature Review of Hyaline Fibromatosis Syndrome trials Research Report on Hyaline Fibromatosis Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pediatric Arthropathy Beyond Inflammation: Clinical Spectrum and Diagnostic Approach at Assiut University Children Hospital
Mucopolysaccharidoses, Progressive Pseudorheumatoid Dysplasia
Not yet recruitingAssiut University352025-09-012025-09-15
Biomarker for Hyaline Fibromatosis Syndrome (BioHFS)
Hyalinosis, Hyaline Membrane Disease
WithdrawnCENTOGENE GmbH Rostock2018-08-202023-02-13
Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome
Cream, 0.1% Uracil Cream - Palmar-Plantar Erythrodysesthesia, Breast Cancer
Phase 1 / Phase 2CompletedNanometics (d.b.a. PHD Biosciences)182010-04-012019-10-08

Narrower conditions

Arthropathy, progressive pseudorheumatoid, of childhood (1)  ·  Breast Neoplasms (1)  ·  Farber Lipogranulomatosis (1)  ·  Hand-Foot Syndrome (1)  ·  Hyaline Membrane Disease (1)  ·  Mucopolysaccharidoses (1)  ·  Osteogenesis Imperfecta (1)  ·  Osteolysis, Essential (1)  ·  Skin and Connective Tissue Diseases (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Skin Diseases (3)  ·  Skin Diseases, Genetic (3)  ·  Skin and Connective Tissue Diseases (2)  ·  Bone Diseases (1)  ·  Bone Diseases, Developmental (1)  ·  Bone Resorption (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Breast Diseases (1)  ·  Carbohydrate Metabolism, Inborn Errors (1)  ·  Central Nervous System Diseases (1)  ·  Chemically-Induced Disorders (1)

Sponsors

Assiut University (1)  ·  CENTOGENE GmbH Rostock (1)  ·  Nanometics (d.b.a. PHD Biosciences) (1)

Countries

Germany (1)  ·  India (1)  ·  Sri Lanka (1)  ·  United States (1)

Top investigators

James Cantrell, MD (1)  ·  Peter Bauer, Prof. (1)

Results publications

PMID 22210669, PMID 23666771, PMID 26388606, PMID 26610319, PMID 28595941, PMID 30805524, PMID 34430024, PMID 3591830, PMID 37927741, PMID 39246942, PMID 9561014